ELDON BIOLOGICALS A/S: Financial statements 2015
CVR: 26747007
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 6,061,341 and a net result of DKK 1,501,774 compared with DKK 1,067,436 the year before. That is an increase of 23.7% compared with the year before. Equity amounted to DKK 318,935. The solvency ratio was 4.9%.
- Gross Profit
- 6,061,341 kr.
- Profit/Loss
- 1,501,774 kr.
- Equity
- 318,935 kr.
- Total Assets
- 6,455,327 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 6.1 mio. | 1.5 mio. | 319 t. | - |
| 2014 | - | 4.9 mio. | 1.1 mio. | -1.2 mio. | - |
| 2013 | - | 4.1 mio. | 949 t. | -2.3 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity amounted to DKK 42,055,949.
